Cytos is a public biopharmaceutical company focused on the development of targeted immunotherapies with a VLP B-cell vaccines platform and ongoing preclinical development programs based on the platform.

Contact Information

Cytos Biotechnology AG, Wagistrasse 25
Schlieren 8952


Total FundingEmployeesLast Funding DateStatus

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2005-03-11$18,574,341Post Ipo Equity
2000-07-26$32,000,000Series BAlta Partners, New Medical Technologies, Lombard Odier, Novartis, Global Life Science Ventures, Aventic Partners AG, HealthCap
2012-03-21$40,000,000Post Ipo EquityvenBio Partners, Abingworth, Aisling Capital, Amgen Ventures
2002-01-23$27,000,000Series C
1999-01-01$7,999,709Series ANovartis, Global Life Science Ventures